首页 | 本学科首页   官方微博 | 高级检索  
     

异基因造血干细胞移植后EB病毒相关性淋巴细胞增殖性疾病研究进展
引用本文:张春丽. 异基因造血干细胞移植后EB病毒相关性淋巴细胞增殖性疾病研究进展[J]. 白血病.淋巴瘤, 2012, 21(8): 504-507
作者姓名:张春丽
作者单位:100044,北京大学人民医院血液科北京大学血液病研究所造血干细胞移植治疗血液病北京市重点实验室
基金项目:卫生行业科研专项公益基金项目
摘    要: 【摘要】 移植后淋巴细胞增殖性疾病(PTLD)是异基因造血干细胞移植(allo-HSCT)后的一种严重并发症,发病多数与EB病毒感染有关,可以有多种形式的临床表现及病理类型。早期PTLD进展迅速,死亡率高,需要临床医生及早做出诊断。现就allo-HSCT后PTLD流行病学、发病机制、临床表现、诊治及预后等方面的最新进展进行综述。

关 键 词:淋巴细胞增殖性疾病  异基因造血干细胞移植  EB病毒

Research progress on Epstein-Barr virus associated post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
ZHANG Chun-li. Research progress on Epstein-Barr virus associated post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation[J]. Journal of Leukemia & Lymphoma, 2012, 21(8): 504-507
Authors:ZHANG Chun-li
Affiliation:. Department of Hematology ,People 's Hospital of Peking University, Peking University Institute of Hematology, Key Laboratory of Beijing on Treatment of Hematologic Diseases with Hematopoietic Stem Cell Transplantation, Beijing 100044, China
Abstract:Post-transplant lymphoproliferative disorders (PTLD) is one of the most potentially life- threatening complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and is mostly associated with Epstein-Barr virus infection. PTLD may have a wide range of clinical manifestations and pathological classifications. The rapid progression and high fatality of early PTLD should prompt clinicians to a timely diagnosis. This paper presents a review of the latest update on epidemiology, pathogenesis, clinical manifestations, diagnosis, management and prognosis of post allo-HSCT PTLD.
Keywords:Lymphoproliferative  disorders  Allogeneic  hematopoietic  stem  cell  transplantation  Epstein-Barr  virus
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《白血病.淋巴瘤》浏览原始摘要信息
点击此处可从《白血病.淋巴瘤》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号